Olanzapine/Samidorphan
Olanzapine/Samidorphan is an investigational combination therapy designed to deliver the antipsychotic efficacy of olanzapine for schizophrenia and bipolar I disorder while counteracting olanzapine-induced weight gain through opioid receptor blockade. This single-tablet formulation is a subject of research in preclinical and clinical studies exploring metabolic side effect mitigation.
Product Specifications
CAS Number
132539-06-1/852626-89-2
Field of Research
Pharmacology & Drug Discovery
Smiles
CN1CCN (CC1) C1=Nc2ccccc2Nc2sc (C) cc12.NC (=O) c1ccc2C[C@H]3N (CC4CC4) CC[C@@]4 (CC (=O) CC[C@@]34O) c2c1O
Molecular Formula
C38H46N6O4S
Molecular Weight
682.88
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-33224M-PE-Cy5 100 µL
GRP78/Bip Monoclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details NB-E10483-01 96 Well
Human deoxyribonucleic protein antibody, DNP-Ab ELISA Kit
Sign In for Pricing
View Details NB-E10483-02 96 Well
Human deoxyribonucleic protein antibody, DNP-Ab ELISA Kit
Sign In for Pricing
View Details